Home › NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara in Europe
 

Keywords :   


NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara in Europe

2014-01-04 07:51:40| Biotech - Topix.net

NPS Pharmaceuticals, Inc. , a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara for the treatment of hypoparathyroidism.

Tags: europe drug receives designation

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Atlantic Tropical Weather Outlook
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Public Advisory Number 3A
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Eastern North Pacific Tropical Weather Outlook
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
More »